Chewy insiders dump $8.8 B in shares, zero buying over 12 months
Chewy, Inc. (CHWY) saw no insider purchases and $8.76 billion of sales in the past year, driving a buy‑sell ratio of 0.00x. The flurry of sales, especially five $1.15 billion blocks on June 25 2025, signals a stark divergence between insider sentiment and the stock’s current price of $21.47.
Over the last twelve months Chewy insiders executed 35 transactions totaling $8,759,788,520 in sales and no purchases, yielding a buy‑sell ratio of 0.00x—well below the 0.2x threshold that flags heavy insider selling. Ten distinct insiders were involved, with the bulk of volume coming from entities that collectively own 10 % of the company. On June 25 2025, five related holdings—Argos Holdings GP LLC, Argos Holdings L.P., CIE Management IX Ltd, BC Partners Holdings Ltd, and Citrus Intermediate Holdings L.P.—each sold 27,544,910 shares for $1,149,999,992, amounting to $5.75 billion in a single day. This cluster of sales, all within a 30‑day window, meets the definition of a coordinated signal and underscores a decisive move by major shareholders to liquidate positions.
The CEO contributed eight sales totaling $5,449,081, while the CFO’s lone transaction was a modest $81,765. Other C‑suite members sold $4,257,715 across eleven trades. Although C‑suite sales often reflect routine diversification or tax planning, the magnitude here—especially the CEO’s multi‑million divestments—adds weight to the bearish narrative. The absence of any insider buying further erodes confidence, as the buy‑sell ratio remains at the floor of the scale.
Chewy’s market context amplifies the concern. The stock trades at $21.47, down 35.6 % YTD, with a 14‑day RSI of 20, indicating oversold conditions but also a prolonged downtrend. The 52‑week range position sits at the lower bound, and the market cap of $8.9 B reflects the erosion of value despite the company’s strong brand presence. While a low RSI can attract contrarian buyers, the sheer scale of insider exits—$8.76 billion in sales, representing roughly 98 % of the total insider transaction value—suggests that insiders are not merely rebalancing but are actively reducing exposure.
Historical monthly patterns reveal spikes in June 2024 ($3.30 billion), September 2024 ($3.95 billion), December 2024 ($3.13 billion), and June 2025 ($6.25 billion). These periods align with the large block sales by the 10 % owner, indicating that the majority of the sell‑off is driven by a single stakeholder rather than a broad base of directors. Nonetheless, the cumulative effect is a market signal that insiders, who possess the most granular view of the company’s prospects, are markedly disengaged.
Investors should weigh the disparity between insider activity and the stock’s current valuation. The data points to a decisive retreat by those closest to the company, a factor that traditionally precedes further price weakness. While the low RSI could tempt opportunistic buyers, the absence of insider buying and the historic scale of sales counsel caution.
Monthly Insider Activity
Activity by Role
Financial Details
| Buy Count | 0 |
| Sell Count | 35 |
| Buy Value | 0.00 |
| Sell Value | 8,759,788,520.20 |
| Total Value | 8,759,788,520.20 |
| Buy Sell Ratio | 0.00 |
| C Suite Activity | Yes |
Key Takeaways
- Buy‑sell ratio over 12 months: **0.00x**, indicating heavy insider selling.
- Total insider sales: **$8.76 billion** across 35 transactions; no purchases.
- Five related 10 % owner entities each sold **$1.15 billion** on June 25 2025.
- CEO sold **$5.45 million** in eight trades; CFO’s sale was **$81,765**.
- Stock price $21.47, down **35.6 % YTD**, RSI 20, market cap $8.9 B.